MEGACE

LOE Approaching

megestrol acetate

NDAORALTABLET
Approved
Aug 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8

Clinical Trials (5)

NCT04939090Phase 3Recruiting

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Started Jan 2022
360 enrolled
Advanced Malignant Solid NeoplasmAnorexiaHematopoietic and Lymphoid Cell Neoplasm
NCT01650168N/ACompleted

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

Started Jul 2012
101,498 enrolled
Contraception
NCT00910091Phase 2Completed

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Started Aug 2009
73 enrolled
Endometrial Cancer
NCT01237327Phase 3Completed

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Started Nov 2001
84 enrolled
Metastatic Breast Cancer
NCT00000737Phase 1Completed

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

56 enrolled
CachexiaHIV InfectionsHIV Wasting Syndrome